🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this trial is to determine the effect of HuMax-CD4 as a trea...
Status
Completed
Location
Stanford University Med. Ctr., Dept. of Dermatology
Start Date
2003-04-30
Trial ID
NCT00071071
The purpose of this study is to assess the safety and efficacy of treatment...
Status
Completed
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT00877656
Treatments Being Tested
Background: * Aldesleukin (IL-2) is a drug that can help to shrink tumors ...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2010-06
Trial ID
NCT01160445
Treatments Being Tested
The purpose of this study is to determine the efficacy of the drug, HuMax-C...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2005-07
Trial ID
NCT00127881
Treatments Being Tested
The purpose of this trial is to determine the effect of HuMax-CD4, as a tre...
Status
Completed
Location
Stanford University Med Ctr., Dept of Dermatology
Start Date
2003-05-27
Trial ID
NCT00071084
The purpose of this study is to determine whether HuMax-CD4 is effective in...
Status
Terminated
Location
Rheumatology Associates
Start Date
2002-03-04
Trial ID
NCT00042406